[HTML][HTML] Natural products for combating multidrug resistance in cancer
T Chen, Z **ao, X Liu, T Wang, Y Wang, F Ye… - Pharmacological …, 2024 - Elsevier
Cancer cells frequently develop resistance to chemotherapeutic therapies and targeted
drugs, which has been a significant challenge in cancer management. With the growing …
drugs, which has been a significant challenge in cancer management. With the growing …
[HTML][HTML] Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents
Cancer is one of the leading causes of death and significantly burdens the healthcare
system. Due to its prevalence, there is undoubtedly an unmet need to discover novel …
system. Due to its prevalence, there is undoubtedly an unmet need to discover novel …
[HTML][HTML] Notch signaling: an emerging therapeutic target for cancer treatment
X Yuan, H Wu, H Xu, H **ong, Q Chu, S Yu, GS Wu… - Cancer letters, 2015 - Elsevier
The Notch pathway is involved in cell proliferation, differentiation and survival. The Notch
signaling pathway is one of the most commonly activated signaling pathways in cancer …
signaling pathway is one of the most commonly activated signaling pathways in cancer …
Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets
In spite of billions of dollars expended on cancer research every year, the incidence rate and
the mortality rate due to this widespread disease has increased drastically over the last few …
the mortality rate due to this widespread disease has increased drastically over the last few …
Honokiol: a review of its anticancer potential and mechanisms
Cancer is characterised by uncontrolled cell division and abnormal cell growth, which is
largely caused by a variety of gene mutations. There are continuous efforts being made to …
largely caused by a variety of gene mutations. There are continuous efforts being made to …
Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells
VR Silva, LS Santos, RB Dias… - Cancer …, 2021 - Wiley Online Library
Colorectal cancer (CRC) represents the third most commonly diagnosed cancer and the
second leading cause of cancer death worldwide. The modern concept of cancer biology …
second leading cause of cancer death worldwide. The modern concept of cancer biology …
Colon cancer stem cells: Potential target for the treatment of colorectal cancer
Despite incessant research, colon cancer still is one of the most common causes of fatalities
in both men and women worldwide. Also, nearly 50% of patients with colorectal cancer show …
in both men and women worldwide. Also, nearly 50% of patients with colorectal cancer show …
Cancer stem cells and their niche in cancer progression and therapy
Q Liu, Z Guo, G Li, Y Zhang, X Liu, B Li, J Wang… - Cancer Cell …, 2023 - Springer
High recurrence and metastasis rates and poor prognoses are the major challenges of
current cancer therapy. Mounting evidence suggests that cancer stem cells (CSCs) play an …
current cancer therapy. Mounting evidence suggests that cancer stem cells (CSCs) play an …
Targeting cancer stem cells and signalling pathways through phytochemicals: A promising approach against colorectal cancer
W Liao, L Zhang, X Chen, J **ang, Q Zheng, N Chen… - Phytomedicine, 2023 - Elsevier
Abstract Background Cancer stem cells (CSCs) are strongly associated with high
tumourigenicity, chemotherapy or radiotherapy resistance, and metastasis and recurrence …
tumourigenicity, chemotherapy or radiotherapy resistance, and metastasis and recurrence …
Notch1 in cancer therapy: possible clinical implications and challenges
The Notch family consists of four highly conserved transmembrane receptors. The release of
the active intracellular domain requires the enzymatic activity of γ-secretase. Notch is …
the active intracellular domain requires the enzymatic activity of γ-secretase. Notch is …